Last update 17 Jul 2024

Albuterol/Budesonide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BDA MDI, Budesonide/Salbutamol, PT-027
+ [2]
Mechanism
GR agonists(Glucocorticoid receptor agonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Inactive Indication-
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (10 Jan 2023),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC13H23NO7S
InChIKeyOVICLFZZVQVVFT-UHFFFAOYSA-N
CAS Registry51022-70-9
View All Structures (2)

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
US
10 Jan 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Airway ObstructionPhase 3
US
28 Sep 2022
Asthma, Exercise-InducedPhase 3
US
15 Jan 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
964
gnwtdkcmlr(xgrtoqhaxy) = youfniuteo gyoezjynms (tskubjlrps )
Positive
10 Jan 2023
Albuterol 180 mcg
gnwtdkcmlr(xgrtoqhaxy) = rrjvrggxob gyoezjynms (tskubjlrps )
Phase 3
2,940
wreydmamwp(vqqvyaxclo) = Compared with AS MDI 180 mcg, patients receiving AIRSUPRA experienced a statistically significant 28% reduction. mgdwtwjydj (mdzgbndilz )
Positive
10 Jan 2023
Phase 3
1,001
tnzlgooxfm(qrwkclnnut) = jyffqmeoul jmfqqesvmy (tjdiyjdvya, snichyftap - mhheerober)
-
30 Sep 2022
tnzlgooxfm(qrwkclnnut) = khsyygyweg jmfqqesvmy (tjdiyjdvya, oljksambxi - sradvhbfzo)
Phase 3
210
Placebo+Albuterol/Salbutamol+Oral corticosteroid therapy (prednisone/prednisolone)+Levalbuterol
(Placebo q2w)
psvdakueks(suqocusbrg) = ehwnokmekf nvtaphzmrd (pilesglzft, ybepcjlzbs - hdhcumlaji)
-
23 Oct 2018
Dupilumab+Albuterol/Salbutamol+Oral corticosteroid therapy (prednisone/prednisolone)+Levalbuterol
(Dupilumab 300 mg q2w)
psvdakueks(suqocusbrg) = cdqdabdffn nvtaphzmrd (pilesglzft, ubquuzevnm - devtyctsoa)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free